Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer ( SENTIVUC II)

NCT06161428 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06161428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer ( SENTIVUC II)
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2023
Completion date
July 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sentinel lymph node, vulva cancer